Jump to:
Inspecs Group PLC Fundamentals
| Company Name | Inspecs Group PLC | Last Updated | 2024-11-27 |
|---|
| Industry | Medical Instruments & Supplies | Sector | Healthcare |
|---|
| Shares in Issue | 101.672 m | Market Cap | £52.31 m |
|---|
| PE Ratio | 0.34 | Dividend per Share | 0 |
|---|
| Dividend Yield | 0 | Dividend Cover | 0 |
|---|
| EPS | -£0.01 | EPS Growth (%) | 0 |
|---|
| PEG | 0 | DPS Growth (%) | 0 |
|---|
| Debt Ratio | 0.2826 | Debt Equity Ratio | 0.4474 |
|---|
| Asset Equity Ratio | 2.1409 | Cash Equity Ratio | 0.2415 |
|---|
| Quick Ratio | 0.8266 | Current Ratio | 1.46 |
|---|
| Price To Book Value | 0.5086 | ROCE | 0 |
|---|
Inspecs Group PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
| Prelim | 2022-09-01 | 2022-10-06 | GBP | 0.0125 | |
Inspecs Group PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|
| Tangible Assets | £35.60 m | £37.11 m | £34.70 m |
| Intangible Assets | £85.39 m | £91.75 m | £96.62 m |
| Investments | £98,000.00 | £112,000.00 | £35,565.12 |
| Total Fixed Assets | £123.92 m | £130.80 m | £140.65 m |
| Stocks | £40.85 m | £48.16 m | £41.24 m |
| Debtors | £33.66 m | £28.88 m | £28.77 m |
| Cash & Equivalents | £20.07 m | £22.15 m | £22.05 m |
| Other Assets | £2.83 m | £1.83 m | £9.29 m |
| Total Assets | £221.91 m | £236.77 m | £237.80 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|
| Creditors within 1 year | £65.86 m | £106.95 m | £61.44 m |
| Creditors after 1 year | £52.53 m | £22.27 m | £68.77 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £118.39 m | £129.23 m | £130.21 m |
| Net assets | £103.52 m | £107.54 m | £107.59 m |
| Equity | 2023 | 2022 | 2021 |
|---|
| Called up share capital | £1.02 m | £1.02 m | £1.03 m |
| Share Premium | £89.51 m | £89.51 m | £90.61 m |
| Profit / Loss | £215,000.00 | -£7.66 m | -£6.77 m |
| Other Equity | £103.52 m | £107.54 m | £107.59 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £103.52 m | £107.54 m | £107.59 m |
| Ratios | 2023 | 2022 | 2021 |
|---|
| Debt Ratio | £0.32 | £0.13 | £0.32 |
| Debt-to-Equity | £0.47 | £0.15 | £0.48 |
| Assets / Equity | 2.1409 | 2.1409 | 2.1409 |
| Cash / Equity | 0.2415 | 0.2415 | 0.2415 |
| EPS | -£0.01 | -£0.05 | -£0.02 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|
| Cash from operating activities | £12.66 m | £4.00 m | £14.83 m |
| Cashflow before financing | £3.83 m | £447,000.00 | £16.09 m |
| Increase in Cash | -£2.35 m | -£3.00 m | £4.49 m |
| Income | 2023 | 2022 | 2021 |
|---|
| Turnover | £203.29 m | £200.96 m | £182.62 m |
| Cost of sales | £99.75 m | £102.10 m | £96.84 m |
| Gross Profit | £103.55 m | £98.86 m | £85.78 m |
| Operating Profit | £2.89 m | -£1.19 m | £1.14 m |
| Pre-Tax profit | £215,000.00 | -£7.66 m | -£6.77 m |
Inspecs Group PLC Company Background
| Sector | Healthcare |
|---|
| Activities | Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. Its customers include optical and Non-optical retailers, global distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Savile Row, Farah, Hype, and Nascar among others. |
|---|
| Latest Interim Date | 10 Sep 2024 |
|---|
| Latest Fiscal Year End Date | 17 Apr 2024 |
|---|
Inspecs Group PLC Directors
| Appointed | Name | Position |
|---|
| 2022-10-27 | Lord Ian MacLaurin | Non-Executive Director,Chairman |
| 2024-04-17 | Mr. Robin Bjorn Christian Totterman | Executive Director,Chairman |
| 2024-04-17 | Mr. Christopher Kay | Executive Director,Chief Financial Officer |
| 2024-04-17 | Mr. Christopher Hancock | Non-Executive Director,Senior Independent non-executive Director |
| 2024-04-17 | Mr. Richard Peck | Executive Director,Chief Executive Officer |
| 2024-04-17 | Ms. Angela Trudie Farrugia | Non-Executive Director |
| 2024-04-17 | Mr. Hugo James Adams | Non-Executive Director |
Inspecs Group PLC Contact Details
Inspecs Group PLC Advisors
